← Back to All Filings

Bristol Myers Squibb EVP Karin Shanahan Reports Tax Withholding Following RSU Vesting

Low SignificanceNovember 3, 2026 at 5:06:59 PM EST

BRISTOL MYERS SQUIBB CO

$BMY4CIK: 0000014272

Subscribe to track BMY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Insider Transaction: BRISTOL MYERS SQUIBB CO ($BMY)
**Reporting Owner:** Karin Shanahan (EVP, Chief Supply Chain & Ops)
**Filing Date:** 2026-11-03 | **Transaction Date:** 2026-11-01

### Summary
- **Transaction:** Tax Withholding (Code F)
- **Shares Withheld:** 3,213 @ $62.48
- **Total Withholding Value:** $200,748.24
- **Direct Shares Owned After:** 28,956
- **Indirect Ownership:** 1,457.717 (via 401(k) / BMS Savings & Investment Program)
- **Related Action:** Vesting of 6,281 Restricted Stock Units (Code M)

*Significance: Low (Routine equity vesting and statutory tax withholding)*

Comprehensive Analysis

Executive Summary

On November 3, 2026, Bristol Myers Squibb Co ($BMY) filed a Form 4 for Karin Shanahan, Executive Vice President, Chief Supply Chain & Operations. The transaction reported is routine equity compensation vesting and subsequent tax withholding that took place on November 1, 2026.

Transaction Breakdown

  1. Derivative Conversion (Code M):

    • Karin Shanahan acquired 6,281 shares of Common Stock through the vesting of one-third of a Restricted Stock Unit (RSU) award originally granted on November 1, 2024.
    • Conversion price: $0.00.
  2. Tax Withholding Disposition (Code F):

    • 3,213 shares of common stock were surrendered to the issuer at a price of $62.48 per share to satisfy statutory tax withholding requirements.
    • Total disposition value: $200,748.24.
  3. Post-Transaction Holdings:

    • Direct beneficial ownership stands at 28,956 shares of Common Stock.
    • Indirect beneficial ownership stands at 1,457.717 shares held via the BMS Savings and Investment Program (401(k)).
    • Derivative holdings include 6,281 unvested RSUs remaining under the award.

Trading Significance

This filing carries Low trading significance. The disposition was not an open-market discretionary sale; rather, it was an automatic withholding of shares to cover tax liabilities associated with scheduled equity vesting under company compensation plans.

Topics:#BMY#BristolMyersSquibb#InsiderTrading#Form4#Biotech#Pharma

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.